Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece; and
Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece; and.
FASEB J. 2015 Feb;29(2):611-22. doi: 10.1096/fj.14-252189. Epub 2014 Nov 13.
Protein homeostasis (proteostasis) is one of the nodal points that need to be preserved to retain physiologic cellular/organismal balance. The ubiquitin-proteasome system (UPS) is responsible for the removal of both normal and damaged proteins, with the proteasome being the downstream effector. The proteasome is the major cellular protease with progressive impairment of function during aging and senescence. Despite the documented age-retarding properties of proteasome activation in various cellular models, simultaneous enhancement of the 20S core proteasome content, assembly, and function have never been reported in any multicellular organism. Consequently, the possible effects of the core proteasome modulation on organismal life span are elusive. In this study, we have achieved activation of the 20S proteasome at organismal level. We demonstrate enhancement of proteasome levels, assembly, and activity in the nematode Caenorhabditis elegans, resulting in life span extension and increased resistance to stress. We also provide evidence that the observed life span extension is dependent on the transcriptional activity of Dauer formation abnormal/Forkhead box class O (DAF-16/FOXO), skinhead-1 (SKN-1), and heat shock factor-1 (HSF-1) factors through regulation of downstream longevity genes. We further show that the reported beneficial effects are not ubiquitous but they are dependent on the genetic context. Finally, we provide evidence that proteasome core activation might be a potential strategy to minimize protein homeostasis deficiencies underlying aggregation-related diseases, such as Alzheimer's disease (AD) or Huntington's disease (HD). In summary, this is the first report demonstrating that 20S core proteasome up-regulation in terms of both content and activity is feasible in a multicellular eukaryotic organism and that in turn this modulation promotes extension of organismal health span and life span.
蛋白质动态平衡(proteostasis)是维持生理细胞/机体平衡所必需的节点之一。泛素-蛋白酶体系统(UPS)负责清除正常和受损的蛋白质,而蛋白酶体是下游效应器。蛋白酶体是主要的细胞蛋白酶,其功能在衰老和衰老过程中逐渐受损。尽管在各种细胞模型中已经证明了蛋白酶体激活具有延缓衰老的特性,但在任何多细胞生物中,从未报道过同时增强 20S 核心蛋白酶体的含量、组装和功能。因此,核心蛋白酶体调节对生物体寿命的可能影响尚不清楚。在这项研究中,我们已经在生物体水平上实现了 20S 蛋白酶体的激活。我们证明了秀丽隐杆线虫 Caenorhabditis elegans 中蛋白酶体水平、组装和活性的增强,导致寿命延长和应激抗性增加。我们还提供了证据表明,观察到的寿命延长依赖于 Dauer formation abnormal/Forkhead box class O (DAF-16/FOXO)、skinhead-1 (SKN-1) 和热休克因子-1 (HSF-1) 转录活性,通过调节下游长寿基因。我们进一步表明,报道的有益效果不是普遍的,而是取决于遗传背景。最后,我们提供了证据表明,核心蛋白酶体的激活可能是一种潜在的策略,可以最小化与聚集相关疾病(如阿尔茨海默病或亨廷顿病)相关的蛋白质动态平衡缺陷。总之,这是第一项证明在多细胞真核生物中,无论是在含量还是在活性方面,20S 核心蛋白酶体的上调都是可行的,并且这种调节促进了生物体健康寿命和寿命的延长。